Vimta Labs P/B Ratio
Vimta Labs (VIMTALABS) P/B ratio is 5.87 (High), book value per share ₹800.00 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Vimta Labs screener.
Current Valuation Metrics
Book Value Breakdown (2024)
Valuation Signal
Sector Context
VIMTALABS P/B Ratio — Valuation Insights & Book Value Analysis
Vimta Labs price-to-book ratio interpretation, valuation status and historical context — current P/B 5.87 (High). Compare with VIMTALABS fair value to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 5.87, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1444.7% above historical average
- Trading at premium to sector average PB of -0.33
Vimta Labs P/B Ratio Historical Trend
VIMTALABS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View VIMTALABS annual price range for the annual high/low range and current price position.
VIMTALABS Historical P/B Ratio — Book Value Per Share & Year-End Price
Vimta Labs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2024 | 0.62 | ₹800.0 | ₹497.10 | ₹320 | Low |
| 2023 | 0.29 | ₹705.0 | ₹201.80 | ₹282 | Low |
| 2022 | 0.37 | ₹585.0 | ₹218.20 | ₹234 | Low |
| 2021 | 0.42 | ₹485.0 | ₹204.50 | ₹194 | Low |
| 2020 | 0.2 | ₹432.5 | ₹87.00 | ₹173 | Low |
VIMTALABS vs Healthcare Peers — P/B Ratio Comparison
Vimta Labs P/B 5.87 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |